| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
289,870,000 |
| Market
Cap: |
68.74(B) |
| Last
Volume: |
967,074 |
Avg
Vol: |
1,406,237 |
| 52
Week Range: |
$230.48 - $283.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 224 |
| Guru Rank Value : 5.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
8,597 |
11,992 |
17,573 |
47,101 |
| Total Sell Value |
$2,028,812 |
$2,830,971 |
$4,382,400 |
$12,101,842 |
| Total People Sold |
3 |
4 |
6 |
8 |
| Total Sell Transactions |
4 |
6 |
10 |
16 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gallagher John E |
VP, Corp Finance and Treasurer |
• – – |
2017-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
434 |
3,645 |
|
- |
|
| Reidy Christopher R |
CFO and EVP of Administration |
• – – |
2017-11-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,767) |
18,418 |
|
- |
|
| Reidy Christopher R |
CFO and EVP of Administration |
• – – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,411 |
25,185 |
|
- |
|
| Forlenza Vincent A |
Chairman, CEO and President |
• • – |
2017-11-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(28,069) |
201,887 |
|
- |
|
| Forlenza Vincent A |
Chairman, CEO and President |
• • – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
33,240 |
229,956 |
|
- |
|
| Conroy Alexandre |
Executive Vice President |
• – – |
2017-11-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,070) |
24,863 |
|
- |
|
| Conroy Alexandre |
Executive Vice President |
• – – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,257 |
28,933 |
|
- |
|
| Borzi James W |
EVP & Chief Supply Chain Offcr |
• – – |
2017-11-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,121) |
2,586 |
|
- |
|
| Borzi James W |
EVP & Chief Supply Chain Offcr |
• – – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,303 |
3,707 |
|
- |
|
| Mas Ribo Alberto |
EVP and Pres, Life Sciences |
• – – |
2017-11-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,191) |
17,934 |
|
- |
|
| Mas Ribo Alberto |
EVP and Pres, Life Sciences |
• – – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,805 |
20,125 |
|
- |
|
| Shabshab Nabil |
Executive Vice President |
• – – |
2017-11-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,782) |
6,262 |
|
- |
|
| Shabshab Nabil |
Executive Vice President |
• – – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,205 |
9,044 |
|
- |
|
| Tharby Linda M |
Executive Vice President |
• – – |
2017-11-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,176) |
11,767 |
|
- |
|
| Tharby Linda M |
Executive Vice President |
• – – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,606 |
14,943 |
|
- |
|
| Goette Roland |
EVP and President, EMEA |
• – – |
2017-11-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(889) |
5,072 |
|
- |
|
| Goette Roland |
EVP and President, EMEA |
• – – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
5,961 |
|
- |
|
| Strahlman Ellen R |
Senior Vice President |
• – – |
2017-11-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,147) |
6,898 |
|
- |
|
| Strahlman Ellen R |
Senior Vice President |
• – – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,008 |
12,045 |
|
- |
|
| Polen Thomas E Jr |
Executive Vice President |
• – – |
2017-11-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,540) |
9,275 |
|
- |
|
| Polen Thomas E Jr |
Executive Vice President |
• – – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,606 |
12,815 |
|
- |
|
| Lim James C |
Executive Vice President |
• – – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,365 |
17,500 |
|
- |
|
| Gallagher John E |
VP, Corp Finance and Treasurer |
• – – |
2017-11-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(933) |
3,211 |
|
- |
|
| Gallagher John E |
VP, Corp Finance and Treasurer |
• – – |
2017-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,483 |
4,144 |
|
- |
|
| Borzi James W |
EVP & Chief Supply Chain Offcr |
• – – |
2017-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
112 |
|
- |
|
1854 Records found
|
|
Page 22 of 75 |
|
|
0.83 (0.35%) 
